PS 47 - CAS 1180676-33-8
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C17H15ClO2
Molecular Weight:
286.75
COA:
Inquire
Targets:
PDK-1
Description:
PS 47 is an inactive E-isomer of the PDK1 activator PS 48. In combination with PS 48, PS 47 can be used as a negative control.
Brife Description:
PDK1 negative activator
Purity:
99%
Synonyms:
PS-47; PS 47; PS47; (E)-5-(4-Chlorophenyl)-3-phenylpent-2-enoic acid
MSDS:
Inquire
InChIKey:
LLJYFDRQFPQGNY-NTCAYCPXSA-N
InChI:
InChI=1S/C17H15ClO2/c18-16-10-7-13(8-11-16)6-9-15(12-17(19)20)14-4-2-1-3-5-14/h1-5,7-8,10-12H,6,9H2,(H,19,20)/b15-12+
Canonical SMILES:
C1=CC=C(C=C1)C(=CC(=O)O)CCC2=CC=C(C=C2)Cl
1.Microphase Separation within Disk Shaped Aggregates of Triblock Bottlebrushes.
Long M;Shi Y;Zhang K;Chen Y Macromol Rapid Commun. 2016 Apr;37(7):605-9. doi: 10.1002/marc.201500686. Epub 2016 Feb 11.
Well-defined AbBA triblock bottlebrush with poly(N,N-dimethyl acrylamide) (PAm) as A block and polyacrylate, densely grafted with poly(tert-butyl acrylate)-block-polystyrene (PBA-b-PS), as brush bB block is prepared by controlled radical polymerization and click chemistry. The triblock copolymer with a composition of PAm200 -b-b(PBA14 -b-PS47 )167 -b-PAm200 is obtained and is further transformed into PAm200 -b-b(PAA14 -b-PS47 )167 -b-PAm200 by hydrolysis of the PBA segment into poly(acrylic acid) (PAA). In a mixture of N,N-dimethylformamide (DMF) and methanol, a poor solvent of bB block, PAm200 -b-b(PAA14 -b-PS47 )167 -b-PAm200 self-assembled into disk-like platelets, which have an internal lamellar structure by further microphase-separation of PAA-b-PS branches in 2D. Moreover, Ag nanoparticles are aligned by PAA segments along the disk to form a pattern.
2.The Molecular Basis of Polysaccharide Sulfatase Activity and a Nomenclature for Catalytic Subsites in this Class of Enzyme.
Hettle AG;Vickers C;Robb CS;Liu F;Withers SG;Hehemann JH;Boraston AB Structure. 2018 May 1;26(5):747-758.e4. doi: 10.1016/j.str.2018.03.012. Epub 2018 Apr 19.
Sulfatases play a biologically important role by cleaving sulfate groups from molecules. They can be identified on the basis of signature sequences within their primary structures, and the largest family, S1, has predictable features that contribute specifically to the recognition and catalytic removal of sulfate groups. However, despite advances in the prediction and understanding of S1 sulfatases, a major question regards the molecular determinants that drive substrate recognition beyond the targeted sulfate group. Here, through analysis of an endo-4S-ι-carrageenan sulfatase (PsS1_19A) from Pseudoalteromonas sp. PS47, particularly X-ray crystal structures in complex with intact substrates, we show that specific recognition of the substrate leaving group components, in this case carbohydrate, provides the enzyme with specificity for its substrate. On the basis of these results we propose a catalytic subsite nomenclature that we anticipate will form a general foundation for understanding and describing the molecular basis of substrate recognition by sulfatases.
3.Genetic variation in the Staphylococcus aureus 8325 strain lineage revealed by whole-genome sequencing.
Bæk KT;Frees D;Renzoni A;Barras C;Rodriguez N;Manzano C;Kelley WL PLoS One. 2013 Sep 30;8(9):e77122. doi: 10.1371/journal.pone.0077122. eCollection 2013.
Staphylococcus aureus strains of the 8325 lineage, especially 8325-4 and derivatives lacking prophage, have been used extensively for decades of research. We report herein the results of our deep sequence analysis of strain 8325-4. Assignment of sequence variants compared with the reference strain 8325 (NRS77/PS47) required correction of errors in the 8325 reference genome, and reassessment of variation previously attributed to chemical mutagenesis of the restriction-defective RN4220. Using an extensive strain pedigree analysis, we discovered that 8325-4 contains 16 single nucleotide polymorphisms (SNP) arising prior to the construction of RN4220. We identified 5 indels in 8325-4 compared with 8325. Three indels correspond to expected Φ11, 12, 13 excisions, one indel is explained by a sequence assembly artifact, and the final indel (Δ63bp) in the spa-sarS intergenic region is common to only a sub-lineage of 8325-4 strains including SH1000. This deletion was found to significantly decrease (75%) steady state sarS but not spa transcript levels in post-exponential phase. The sub-lineage 8325-4 was also found to harbor 4 additional SNPs. We also found large sequence variation between 8325, 8325-4 and RN4220 in a cluster of repetitive hypothetical proteins (SA0282 homologs) near the Ess secretion cluster.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related PDK-1 Products


CAS 850717-64-5 BX-517

BX-517
(CAS: 850717-64-5)

BX-517, also known as PDK1 inhibitor2, is a cell-permeable indolinone compound that acts as a potent, ATP site-targeting PDK1 inhibitor (IC50 = 6 nM). BX-517 al...

CAS 1180676-33-8 PS 47

PS 47
(CAS: 1180676-33-8)

PS 47 is an inactive E-isomer of the PDK1 activator PS 48. In combination with PS 48, PS 47 can be used as a negative control.

PDK1 inhibitor 2610

PDK1 inhibitor 2610 is an ATP-competitive and selective dual PI3K and PDPK1 inhibitor (IC50 values 34 nM and 94 nM for PDK1 and p-T308-PKB, respectively).

CAS 1180676-32-7 PS 48

PS 48
(CAS: 1180676-32-7)

PS 48 is an allosteric activator of phosphoinositide-dependent protein kinase 1 (PDPK1; PDK1) binding to the PIF-binding pocket of PDK1.

CAS 702675-74-9 BX795

BX795
(CAS: 702675-74-9)

BX795 is a potent and selective inhibitor of PDK1, IKKε and TBK1, which regulates the production of Type 1 interferons during bacterial and viral infection. BX7...

CAS 1001409-50-2 PDK1 inhibitor

PDK1 inhibitor
(CAS: 1001409-50-2)

PDK1 inhibitor is a potent and selective inhibitor of PDK1 with potential as anticancer agent.

CAS 702674-56-4 BX912

BX912
(CAS: 702674-56-4)

BX-912 is a selective inhibitor of 3-Phosphoinositide-dependent Kinase-1 (PDK1) with IC50 of 12 nM; >10 fold selectivity over PKA, PKC, C-Kit, EGFR etc.

CAS 742112-33-0 OSU 03012

OSU 03012
(CAS: 742112-33-0)

OSU 03012 is an orally available, targeted anti-cancer agent that has been shown in pre-clinical studies to inhibit PDK-1, a protein in the PI3K/Akt pathway tha...

Chemical Structure

CAS 1180676-33-8 PS 47

Quick Inquiry

Verification code

Featured Items